This document provides a summary and table of contents for a market research report on the Indian coronary stent market forecast to 2019. The report contains 10 chapters analyzing topics such as the demographic and economic landscape in India, regulations for medical devices, taxation, the industry and production, import/export trends, consumers, pricing, the current market size and outlook. It aims to provide decision-makers in the coronary stent manufacturing industry with insights into market dynamics and growth opportunities in India.
Market Research Report : Coronary stents market in india 2014 - SampleNetscribes, Inc.
For the complete report, get in touch with us at: info@netscribes.com
Abstract:
Netscribes latest market research report titled Coronary Stents Market in India 2014 states that manufacturers of coronary stents are experiencing high demand for their products due to a number of reasons. With cardiovascular diseases becoming a common occurrence amongst Indians and the healthcare infrastructure in the country rapidly improving, the number of angioplasty procedures being carried out in the country has increased significantly. Advancements in technology has resulted in patients being more receptive towards stent implants. The products available in the market can be divided into two types - those manufactured by MNCs and commanding high prices, and those manufactured by domestic companies and generally having lower prices. The general perception is that stents manufactured by MNCs are superior in terms of quality and efficacy whereas those manufactured by domestic companies fail to attain similar high quality. As a result, the MNCs serve majority of the market with almost all the big hospitals in tier I cities preferring to implant stents manufactured by foreign companies.
Since the medical equipments and devices industry in India has not been given any separate legal status and coronary stents have been classified as drugs under the provisions of the Drugs & Cosmetics Act, 1940, the Central Drugs Standard Control Organization (CDSCO) is responsible for the regulation of stents in the country. The significant reduction in reimbursement rates for stents under the Central Government Health Scheme (CGHS) in Feb 2013 and a further reduction in the reimbursement rates in Apr 2014 has badly affected manufacturers, especially the MNCs. Although majority of the angioplasties performed in the country are done in private establishments with only a few being done under the CGHS, the reduction in the reimbursement rates is likely to force companies to lower price in the open market as well. However, despite a fall in price of products, the market is still expected to grow steadily. Moreover, the penetration of cath labs in the smaller cities and towns has made angioplasty more accessible to patients and is expected to boost demand for stents.
Table of Contents:
Market Research Report :Coronary stents market in india 2013Netscribes, Inc.
For the complete report, get in touch with us at : info@netscribes.com
Abstract:
Netscribes’ latest market research report titled Coronary stents Market in India 2013 states that manufacturers of coronary stents are experiencing high demand for their products due to a number of factors. Since cardiovascular diseases have become a common occurrence among the Indian population and the healthcare infrastructure in the country is rapidly improving, it has built a strong case for angioplasty procedures in the country. Moreover, an increase in awareness and the willingness to spend on healthcare is benefiting the market. Also, advancements in technology such as the introduction of bioabsorbable stents in the Indian market in December 2012 has made such stents more acceptable to patients, thereby providing further stimulus for market growth. With growth in the number of cath labs in the country and their subsequent expansion to smaller cities and towns, angioplasties will become more accessible to patients and will aid in further development of the market.
Products available in the market can be divided into two types – those manufactured by MNCs that command high prices, and those manufactured by domestic companies that are generally priced lower. It is the MNCs that serve the majority of the market with almost all the big hospitals in tier I cities, where most of the angioplasties are performed, preferring to implant stents manufactured by foreign companies over those manufactured by their Indian counterparts. The general perception is that stents manufactured by MNCs are superior in terms of quality and efficacy, whereas those manufactured by domestic companies fail to attain similar high standards of quality. Also, patients are generally unaware of the choices they have in terms of the types of stents and the various brands that are available in the market, and have to buy stents directly from the hospitals. Since profit margins are higher in case of foreign-manufactured stents, hospitals push for the sale of such stents rather than selling the Indian varieties.
Table of Contents:
The world stents market would reach $16,666 million by 2022. A stent is a tube like implant that is implanted into the lumen of any blood vessel or a duct in order to keep the passage open. Varieties of stents for different clinical conditions are available in the market. A stent implant is most commonly used for the treatment of cardiac abnormalities such as blocked blood vessels. In addition, stents are implanted in the esophagus to allow the passage of food and beverages in patients suffering from esophageal cancer.
Read here at: https://www.alliedmarketresearch.com/stents-market
Indian in vitro diagnostics market opportunity analysis 2018 - Reports CornerReports Corner
The Indian in vitro diagnostics (IVD) market is valued at over $500 million in 2018 and is expected to reach $1 billion by 2026, growing at a compound annual growth rate of 19%. This remarkable growth can be attributed to increased healthcare awareness, a desire for preventive health checkups, the availability of disease-specific tests, and a shift from manual to more automated equipment. The market is led by global players and lacks local manufacturers who can develop their own products and technologies. The report analyzes the segments of the Indian IVD market and identifies drivers of growth as well as challenges that must be addressed for continued expansion.
This document summarizes a report on the Chinese medical monitor industry from 2010 to early 2011. It provides an overview of the market size, key players, import and export trends of the Chinese medical monitor market. It also analyzes major companies in the industry such as Mindray, GE, Philips, Biolight, and Goldway. The report finds that the market grew over 20% annually from 2007 to 2009 and is expected to continue expanding due to China's growing healthcare needs and aging population. Domestic brands have an increasing presence though international brands still dominate the high-end sector of the market.
India bariatric surgical devices market size, share & forecast 2025TechSci Research
According to www.techsciresearch.com latest Report- India bariatric surgical devices market is expected to grow at a formidable rate during the forecast period. The India bariatric surgical devices market is driven by the growing diabetic population especially Type 2 diabetes. Additionally.
Report URL- https://www.techsciresearch.com/report/india-bariatric-surgical-devices-market/4557.html
This document discusses foreign direct investment (FDI) in India, particularly in the medical devices sector. It provides background on FDI policies in India since 1991. In January 2015, the government allowed up to 100% FDI through the automatic route in the medical devices industry. Previously, FDI in medical devices was considered part of the pharmaceutical sector, where existing companies required approval. The change aims to promote local manufacturing, as India currently imports 70% of its medical devices. It may also lead to more co-investment in existing medical device projects and import substitution. However, some experts note that policies need to support domestic manufacturing to compete with cheaper imports.
Market Research Report : Coronary stents market in india 2014 - SampleNetscribes, Inc.
For the complete report, get in touch with us at: info@netscribes.com
Abstract:
Netscribes latest market research report titled Coronary Stents Market in India 2014 states that manufacturers of coronary stents are experiencing high demand for their products due to a number of reasons. With cardiovascular diseases becoming a common occurrence amongst Indians and the healthcare infrastructure in the country rapidly improving, the number of angioplasty procedures being carried out in the country has increased significantly. Advancements in technology has resulted in patients being more receptive towards stent implants. The products available in the market can be divided into two types - those manufactured by MNCs and commanding high prices, and those manufactured by domestic companies and generally having lower prices. The general perception is that stents manufactured by MNCs are superior in terms of quality and efficacy whereas those manufactured by domestic companies fail to attain similar high quality. As a result, the MNCs serve majority of the market with almost all the big hospitals in tier I cities preferring to implant stents manufactured by foreign companies.
Since the medical equipments and devices industry in India has not been given any separate legal status and coronary stents have been classified as drugs under the provisions of the Drugs & Cosmetics Act, 1940, the Central Drugs Standard Control Organization (CDSCO) is responsible for the regulation of stents in the country. The significant reduction in reimbursement rates for stents under the Central Government Health Scheme (CGHS) in Feb 2013 and a further reduction in the reimbursement rates in Apr 2014 has badly affected manufacturers, especially the MNCs. Although majority of the angioplasties performed in the country are done in private establishments with only a few being done under the CGHS, the reduction in the reimbursement rates is likely to force companies to lower price in the open market as well. However, despite a fall in price of products, the market is still expected to grow steadily. Moreover, the penetration of cath labs in the smaller cities and towns has made angioplasty more accessible to patients and is expected to boost demand for stents.
Table of Contents:
Market Research Report :Coronary stents market in india 2013Netscribes, Inc.
For the complete report, get in touch with us at : info@netscribes.com
Abstract:
Netscribes’ latest market research report titled Coronary stents Market in India 2013 states that manufacturers of coronary stents are experiencing high demand for their products due to a number of factors. Since cardiovascular diseases have become a common occurrence among the Indian population and the healthcare infrastructure in the country is rapidly improving, it has built a strong case for angioplasty procedures in the country. Moreover, an increase in awareness and the willingness to spend on healthcare is benefiting the market. Also, advancements in technology such as the introduction of bioabsorbable stents in the Indian market in December 2012 has made such stents more acceptable to patients, thereby providing further stimulus for market growth. With growth in the number of cath labs in the country and their subsequent expansion to smaller cities and towns, angioplasties will become more accessible to patients and will aid in further development of the market.
Products available in the market can be divided into two types – those manufactured by MNCs that command high prices, and those manufactured by domestic companies that are generally priced lower. It is the MNCs that serve the majority of the market with almost all the big hospitals in tier I cities, where most of the angioplasties are performed, preferring to implant stents manufactured by foreign companies over those manufactured by their Indian counterparts. The general perception is that stents manufactured by MNCs are superior in terms of quality and efficacy, whereas those manufactured by domestic companies fail to attain similar high standards of quality. Also, patients are generally unaware of the choices they have in terms of the types of stents and the various brands that are available in the market, and have to buy stents directly from the hospitals. Since profit margins are higher in case of foreign-manufactured stents, hospitals push for the sale of such stents rather than selling the Indian varieties.
Table of Contents:
The world stents market would reach $16,666 million by 2022. A stent is a tube like implant that is implanted into the lumen of any blood vessel or a duct in order to keep the passage open. Varieties of stents for different clinical conditions are available in the market. A stent implant is most commonly used for the treatment of cardiac abnormalities such as blocked blood vessels. In addition, stents are implanted in the esophagus to allow the passage of food and beverages in patients suffering from esophageal cancer.
Read here at: https://www.alliedmarketresearch.com/stents-market
Indian in vitro diagnostics market opportunity analysis 2018 - Reports CornerReports Corner
The Indian in vitro diagnostics (IVD) market is valued at over $500 million in 2018 and is expected to reach $1 billion by 2026, growing at a compound annual growth rate of 19%. This remarkable growth can be attributed to increased healthcare awareness, a desire for preventive health checkups, the availability of disease-specific tests, and a shift from manual to more automated equipment. The market is led by global players and lacks local manufacturers who can develop their own products and technologies. The report analyzes the segments of the Indian IVD market and identifies drivers of growth as well as challenges that must be addressed for continued expansion.
This document summarizes a report on the Chinese medical monitor industry from 2010 to early 2011. It provides an overview of the market size, key players, import and export trends of the Chinese medical monitor market. It also analyzes major companies in the industry such as Mindray, GE, Philips, Biolight, and Goldway. The report finds that the market grew over 20% annually from 2007 to 2009 and is expected to continue expanding due to China's growing healthcare needs and aging population. Domestic brands have an increasing presence though international brands still dominate the high-end sector of the market.
India bariatric surgical devices market size, share & forecast 2025TechSci Research
According to www.techsciresearch.com latest Report- India bariatric surgical devices market is expected to grow at a formidable rate during the forecast period. The India bariatric surgical devices market is driven by the growing diabetic population especially Type 2 diabetes. Additionally.
Report URL- https://www.techsciresearch.com/report/india-bariatric-surgical-devices-market/4557.html
This document discusses foreign direct investment (FDI) in India, particularly in the medical devices sector. It provides background on FDI policies in India since 1991. In January 2015, the government allowed up to 100% FDI through the automatic route in the medical devices industry. Previously, FDI in medical devices was considered part of the pharmaceutical sector, where existing companies required approval. The change aims to promote local manufacturing, as India currently imports 70% of its medical devices. It may also lead to more co-investment in existing medical device projects and import substitution. However, some experts note that policies need to support domestic manufacturing to compete with cheaper imports.
China medical device industry market demand and investment strategy report, 2...Qianzhan Intelligence
This document provides an overview and analysis of the medical device industry in China. It discusses the industry's definition and importance to the national economy. It also analyzes the industry's policy environment, economic and social factors, technological development, supply and demand characteristics, imports and exports, competitive landscape, and investment trends. The document contains forecasts for the development prospects of various medical device segment industries and product markets in China from 2013 to 2017. It aims to help industry players better understand the market trends and make informed strategic decisions.
The document discusses the Indian medical devices industry. It notes that India imports 75% of its medical devices and the domestic manufacturing is limited and not recognized to international standards. The aim of the study is to understand factors affecting the development of the Indian medical devices industry and actions needed to meet local demand and enable exports. It hypothesizes that factors like government policies, manufacturers' willingness to invest, production capacity, and perceptions of Indian-made devices influence the industry's growth. The research methodology involves both quantitative and qualitative approaches.
Pharmaceutical Offshoring Landscape A Syndicated Reportshekhar619
- The pharmaceutical industry is increasingly offshoring R&D activities to countries like India and China to take advantage of lower costs. India captured $125 million in offshored R&D spending in 2008 and China captured $375 million.
- India has become a major destination for clinical trials and data management due to its large, skilled talent pool and lower costs that are 20-30% of developed markets. The market for outsourced clinical trials in India is growing at 31% annually.
- Pharmaceutical companies are establishing facilities in India's Special Economic Zones which provide tax incentives and regulatory benefits to encourage further offshoring and foreign investment in the country.
This document analyzes the pharmaceutical sector and the company Pfizer. It examines the market share and turnover of the top 10 pharmaceutical companies, finding that Johnson & Johnson has the highest turnover. It also analyzes the labor capital ratio of these companies, determining that Johnson & Johnson has the highest ratio, followed by Pfizer. Forecasting models are developed using Weka and SPSS to predict Pfizer's share price, finding a 94% accurate prediction of an increase in price in late 2014 and stabilization in late August. In conclusion, Pfizer is one of the top pharmaceutical companies globally and demonstrated strong performance.
The Indian in vitro diagnostic market - an overviewSchenella Menda
Looking for data on the Indian IVD market? Here is an overview of the market, its segments and a brief description of every segment. I hope you enjoy reading it.
China pharmaceutical excipients industry indepth research and investment stra...Qianzhan Intelligence
The document discusses China's pharmaceutical excipients industry. It notes that the quality of excipients directly impacts the quality of drug preparations. The development of excipients in China has lagged the pharmaceutical industry. However, recent events have brought increased attention to excipients and driven their development. The report analyzes the industry's environment, market size, competitors, and prospects for development. It aims to provide a comprehensive overview of the current state and future trends in China's pharmaceutical excipients sector.
Market Research Report : Clinical trials market in india 2014 - SampleNetscribes, Inc.
The clinical trials market in India was valued at INR x1 billion in 2013 and is estimated to reach INR x2 billion by 2018, growing at a CAGR of y1%. India's share of the global clinical trials market was y2% in 2013. Key drivers of growth include lower costs, a large patient population, and increasing R&D spending by pharmaceutical companies. However, new regulations have also brought challenges such as delays in approval and a shortage of research professionals. The document provides an overview of the market size and growth drivers, government regulations, and major players in the clinical trials industry in India.
This document provides a sectoral analysis of the stock market focusing on three sectors - Nifty Bank, Nifty IT and Nifty FMCG. It includes analysis of companies within these sectors such as Nestle India, Britannia Industries, HCL Technologies, TCS, LTI, ICICI Bank and Kotak Mahindra Bank. Key highlights from the companies include their quarterly earnings results, recent partnerships, initiatives to deal with COVID-19 impacts, and expectations for the future. The overall analysis examines stock price movements and provides insights on how different sectors and companies within these sectors are performing.
China industrial gas industry market forecast and investment strategic planni...Qianzhan Intelligence
The document provides an overview and analysis of China's industrial gas industry from 2011-2017. It discusses key topics like the industry definition, value chain, market environment, development status, economic indexes, supply and demand balance, imports and exports, and competitive structure. The analysis is based on extensive data collection and aims to help companies understand industry trends and make informed business decisions.
This document summarizes statistics on the clinical research industry. It finds that India has experienced strong growth in clinical trials in recent years and is emerging as a top destination for outsourced clinical research. While the Indian clinical research market is growing rapidly, it remains relatively small compared to the global market and there is a need for more trained professionals to support further industry expansion.
Middle East Medical device Market trend and Entry plan.pdfPeterplanetChen
Middle East region
Medical device market trend in the Middle East
Market trend and entry plan Entry plan
I. Medical device market trends in the Middle East / 2
II. Market trends and entry strategies by country / 61. UAE
2. Qatar
3. Saudi Arabia
4. Kuwait
5. Oman
6. Jordan
7. Egypt
8. Iraq
9. Turkey
10. Israel
Useful materials related to advance into medical devices by country
summary
The medical device market in the Middle East has shown continuous
growth over the past five years.
A key constituent of the Indian economy that accounts for about five percent of the GDP, the Indian chemical industry has vital associations with several other industries such as automotives, consumer durables, food processing, iron and steel, textiles, paper, and engineering, among others. It is the eighth largest sector in the world and the third largest in Asia by volumes, after China and Japan. This report encompasses an assessment of the chemicals industry in India, within the context of the global industry, and the opportunities and challenges it presents. The country’s chemical industry was estimated at USD 91 billion in 2011 and we believe that it has the potential to reach USD 134 billion by 2015 growing at a CAGR of 10 percent. The growth is expected to be driven by rising demand in end-use segments and expanding exports fuelled by increasing export competitiveness. The dynamics that propel the industry, namely opportunities, competition, infrastructure investment and regulatory policies are also studied in the report.
The document discusses India's pharmaceutical industry, including its current size and growth rate. It notes that formulations make up 79% of the industry while bulk drugs account for 21%. The background section outlines how India's Patents Act of 1970 only recognized process patents and led to increased domestic production. It also discusses how India transitioned to a product patent regime in 2005 to comply with TRIPS and how this has impacted multinational companies investing in India.
Market Research Report: Medical Devices Market in India 2010Netscribes, Inc.
For the complete report, get in touch with us at: info@netscribes.com
The medical device market is a thriving segment of the healthcare industry in India. Rise in the number of hospitals and increasing requirement of healthcare facilities is creating a need for sophisticated devices and equipments which can provide accurate treatment to individuals. The global market is growing rapidly and India has also joined the bandwagon of being one of the fastest growing countries in this respect. The government is expected to develop a regulatory structure leading to quality products by manufacturers. However, the regulatory structure currently lacks active participation from the government but with the increase in competition in the sector, it is due to follow in a very short period of time. Currently, imports account for a large share of primarily the high-end medical device segment and players are gearing up establishing large manufacturing facilities in India to tap the opportunities.
The report begins with an introduction of medical devices in India and their classification based on relative parameters set by the Indian Government. The market overview section provides the market size and growth. It also provides an overview of the segments that are existent in the market along with their market share. The import and the export structure of the medical devices in India are also given.
This is followed by an analysis of the drivers fueling growth in the market including increasing hospital infrastructure, increasing healthcare spending, changing demographics and growing target consumer group, increasing lifestyle diseases and therapies and increasing medical tourism in India. The key challenges identified include high dependency on exports and lack of standard regulatory structure. The key trends in the market have also been identified including outsourcing/relocating of manufacturing facilities, increasing joint ventures and tie-ups and various exhibitions and trade fairs.
The involvement of government in this industry is also included. It shows the role of various government bodies that are involved in regulating this sector and also involved in the promotion of this sector in India. It also highlights the regulations set in terms of assessment of a medical device manufacturing organization in India along with the procedure involved in registration of an organization and procurement of an import license. The initiatives taken by the government in order to promote the sector by providing tax reliefs and import duty relaxations have also been highlighted.
The competitive landscape provides a look into the nature of the market, and the active players in the market. A product portfolio matrix is also given to highlight the dominant player in each segments of the market. Profiles of the major domestic and foreign players have been included. Furthermore, key developments in the market over the last one year have also been highlighted.
Covid impact on selected sectors of indian stock market sanika yadavSanika Yadav
This is a study report on the Impact of COVID-19 on selected sectors of the Indian Stock Markets.
The market reflects sentiments of the investors and this time it seems to project a V-shaped recovery indicating the return of normalcy.
But the real question lies in whether it matches the ground reality?
Survival of the fittest -
COVID-19 has compelled businesses to restrategize and revamp their business models to stay relevant. It has lead to many market disruptors resulting in new entrants reaching successes while the traditional businesses struggling to operate.
This report discusses some key impacts on sectors like Pharma, IT and Automobile.
Strategic Analysis of the Indian Pharmaceutical Contract Manufacturing Market...Aiswariya Chidambaram
The Indian Pharmaceutical CMO market has been analyzed and assessed with respect to APIs and finished dose formulations (solids, liquids and injectables). Strategic recommendations for the success of market participants have been provided.
This ppt gives an overview of the Indian Pharmaceutical sector. We have concentrated on 5 aspects of the sector and analysed it. The covered heads are history, business model, Marketing, Competitor analysis, Financials and Trends.
Brief Report on the Indian Pharmaceutical Industry - 2011david_singer
The document summarizes the pharmaceutical industry in India. It provides an overview of the industry, noting that it is highly fragmented with over 20,000 registered units and is a $4.5 billion industry growing annually by 8-9%. It also profiles some of the largest pharmaceutical companies in India, including Ranbaxy, Dr. Reddy's Laboratories, and Cipla, and discusses their operations, market shares, and R&D investments. The industry is a major exporter of generic drugs and has a competitive advantage due to its skilled workforce and cost-effective production capabilities.
China organosilicon industry market demand prospects and investment strategy ...Qianzhan Intelligence
The document provides an overview and analysis of the organosilicon industry in China. It discusses the industry's development trends, market demand prospects, and investment strategies from 2013 to 2017. It analyzes factors such as the industry's structure, key players, market segments, supply and demand dynamics, import/export activities, competitive landscape, and development prospects. The report is intended to help organosilicon manufacturers, R&D institutions, marketing companies, and investors better understand the industry and identify opportunities.
China organosilicon industry market demand prospects and investment strategy ...Qianzhan Intelligence
The document is a report on the organosilicon industry market in China from 2011-2017. It provides an overview of the industry, including definitions and product categories. It also analyzes factors like the industrial chain, development trends, economic indexes, supply and demand balance, import/export market, market environment, and domestic and global competition in the industry. The report aims to help organosilicon companies, R&D institutions, marketing firms, and investors understand the latest industry developments and find opportunities in the growing market.
Stent design aspects and coronary artery disease were discussed. Coronary artery disease is a leading cause of death worldwide. Historical developments in treatments including balloon angioplasty, bare metal stents, and drug-eluting stents were covered. Mechanisms of in-stent restenosis and approaches to prevent it such as mechanical techniques, drug coatings, and biodegradable stents were described. Clinical measures for evaluating restenosis outcomes were defined.
Computer Hub in Ambala ! Batra Computer Centrejatin batra
Batra Computer Centre is An ISO certified 9001:2008 training Centre in Ambala.
We Provide Best Computer Training in Ambala. BATRA COMPUTER CENTRE provides best training in C, C++, S.E.O, Web Designing, Web Development and So many other courses are available.
China medical device industry market demand and investment strategy report, 2...Qianzhan Intelligence
This document provides an overview and analysis of the medical device industry in China. It discusses the industry's definition and importance to the national economy. It also analyzes the industry's policy environment, economic and social factors, technological development, supply and demand characteristics, imports and exports, competitive landscape, and investment trends. The document contains forecasts for the development prospects of various medical device segment industries and product markets in China from 2013 to 2017. It aims to help industry players better understand the market trends and make informed strategic decisions.
The document discusses the Indian medical devices industry. It notes that India imports 75% of its medical devices and the domestic manufacturing is limited and not recognized to international standards. The aim of the study is to understand factors affecting the development of the Indian medical devices industry and actions needed to meet local demand and enable exports. It hypothesizes that factors like government policies, manufacturers' willingness to invest, production capacity, and perceptions of Indian-made devices influence the industry's growth. The research methodology involves both quantitative and qualitative approaches.
Pharmaceutical Offshoring Landscape A Syndicated Reportshekhar619
- The pharmaceutical industry is increasingly offshoring R&D activities to countries like India and China to take advantage of lower costs. India captured $125 million in offshored R&D spending in 2008 and China captured $375 million.
- India has become a major destination for clinical trials and data management due to its large, skilled talent pool and lower costs that are 20-30% of developed markets. The market for outsourced clinical trials in India is growing at 31% annually.
- Pharmaceutical companies are establishing facilities in India's Special Economic Zones which provide tax incentives and regulatory benefits to encourage further offshoring and foreign investment in the country.
This document analyzes the pharmaceutical sector and the company Pfizer. It examines the market share and turnover of the top 10 pharmaceutical companies, finding that Johnson & Johnson has the highest turnover. It also analyzes the labor capital ratio of these companies, determining that Johnson & Johnson has the highest ratio, followed by Pfizer. Forecasting models are developed using Weka and SPSS to predict Pfizer's share price, finding a 94% accurate prediction of an increase in price in late 2014 and stabilization in late August. In conclusion, Pfizer is one of the top pharmaceutical companies globally and demonstrated strong performance.
The Indian in vitro diagnostic market - an overviewSchenella Menda
Looking for data on the Indian IVD market? Here is an overview of the market, its segments and a brief description of every segment. I hope you enjoy reading it.
China pharmaceutical excipients industry indepth research and investment stra...Qianzhan Intelligence
The document discusses China's pharmaceutical excipients industry. It notes that the quality of excipients directly impacts the quality of drug preparations. The development of excipients in China has lagged the pharmaceutical industry. However, recent events have brought increased attention to excipients and driven their development. The report analyzes the industry's environment, market size, competitors, and prospects for development. It aims to provide a comprehensive overview of the current state and future trends in China's pharmaceutical excipients sector.
Market Research Report : Clinical trials market in india 2014 - SampleNetscribes, Inc.
The clinical trials market in India was valued at INR x1 billion in 2013 and is estimated to reach INR x2 billion by 2018, growing at a CAGR of y1%. India's share of the global clinical trials market was y2% in 2013. Key drivers of growth include lower costs, a large patient population, and increasing R&D spending by pharmaceutical companies. However, new regulations have also brought challenges such as delays in approval and a shortage of research professionals. The document provides an overview of the market size and growth drivers, government regulations, and major players in the clinical trials industry in India.
This document provides a sectoral analysis of the stock market focusing on three sectors - Nifty Bank, Nifty IT and Nifty FMCG. It includes analysis of companies within these sectors such as Nestle India, Britannia Industries, HCL Technologies, TCS, LTI, ICICI Bank and Kotak Mahindra Bank. Key highlights from the companies include their quarterly earnings results, recent partnerships, initiatives to deal with COVID-19 impacts, and expectations for the future. The overall analysis examines stock price movements and provides insights on how different sectors and companies within these sectors are performing.
China industrial gas industry market forecast and investment strategic planni...Qianzhan Intelligence
The document provides an overview and analysis of China's industrial gas industry from 2011-2017. It discusses key topics like the industry definition, value chain, market environment, development status, economic indexes, supply and demand balance, imports and exports, and competitive structure. The analysis is based on extensive data collection and aims to help companies understand industry trends and make informed business decisions.
This document summarizes statistics on the clinical research industry. It finds that India has experienced strong growth in clinical trials in recent years and is emerging as a top destination for outsourced clinical research. While the Indian clinical research market is growing rapidly, it remains relatively small compared to the global market and there is a need for more trained professionals to support further industry expansion.
Middle East Medical device Market trend and Entry plan.pdfPeterplanetChen
Middle East region
Medical device market trend in the Middle East
Market trend and entry plan Entry plan
I. Medical device market trends in the Middle East / 2
II. Market trends and entry strategies by country / 61. UAE
2. Qatar
3. Saudi Arabia
4. Kuwait
5. Oman
6. Jordan
7. Egypt
8. Iraq
9. Turkey
10. Israel
Useful materials related to advance into medical devices by country
summary
The medical device market in the Middle East has shown continuous
growth over the past five years.
A key constituent of the Indian economy that accounts for about five percent of the GDP, the Indian chemical industry has vital associations with several other industries such as automotives, consumer durables, food processing, iron and steel, textiles, paper, and engineering, among others. It is the eighth largest sector in the world and the third largest in Asia by volumes, after China and Japan. This report encompasses an assessment of the chemicals industry in India, within the context of the global industry, and the opportunities and challenges it presents. The country’s chemical industry was estimated at USD 91 billion in 2011 and we believe that it has the potential to reach USD 134 billion by 2015 growing at a CAGR of 10 percent. The growth is expected to be driven by rising demand in end-use segments and expanding exports fuelled by increasing export competitiveness. The dynamics that propel the industry, namely opportunities, competition, infrastructure investment and regulatory policies are also studied in the report.
The document discusses India's pharmaceutical industry, including its current size and growth rate. It notes that formulations make up 79% of the industry while bulk drugs account for 21%. The background section outlines how India's Patents Act of 1970 only recognized process patents and led to increased domestic production. It also discusses how India transitioned to a product patent regime in 2005 to comply with TRIPS and how this has impacted multinational companies investing in India.
Market Research Report: Medical Devices Market in India 2010Netscribes, Inc.
For the complete report, get in touch with us at: info@netscribes.com
The medical device market is a thriving segment of the healthcare industry in India. Rise in the number of hospitals and increasing requirement of healthcare facilities is creating a need for sophisticated devices and equipments which can provide accurate treatment to individuals. The global market is growing rapidly and India has also joined the bandwagon of being one of the fastest growing countries in this respect. The government is expected to develop a regulatory structure leading to quality products by manufacturers. However, the regulatory structure currently lacks active participation from the government but with the increase in competition in the sector, it is due to follow in a very short period of time. Currently, imports account for a large share of primarily the high-end medical device segment and players are gearing up establishing large manufacturing facilities in India to tap the opportunities.
The report begins with an introduction of medical devices in India and their classification based on relative parameters set by the Indian Government. The market overview section provides the market size and growth. It also provides an overview of the segments that are existent in the market along with their market share. The import and the export structure of the medical devices in India are also given.
This is followed by an analysis of the drivers fueling growth in the market including increasing hospital infrastructure, increasing healthcare spending, changing demographics and growing target consumer group, increasing lifestyle diseases and therapies and increasing medical tourism in India. The key challenges identified include high dependency on exports and lack of standard regulatory structure. The key trends in the market have also been identified including outsourcing/relocating of manufacturing facilities, increasing joint ventures and tie-ups and various exhibitions and trade fairs.
The involvement of government in this industry is also included. It shows the role of various government bodies that are involved in regulating this sector and also involved in the promotion of this sector in India. It also highlights the regulations set in terms of assessment of a medical device manufacturing organization in India along with the procedure involved in registration of an organization and procurement of an import license. The initiatives taken by the government in order to promote the sector by providing tax reliefs and import duty relaxations have also been highlighted.
The competitive landscape provides a look into the nature of the market, and the active players in the market. A product portfolio matrix is also given to highlight the dominant player in each segments of the market. Profiles of the major domestic and foreign players have been included. Furthermore, key developments in the market over the last one year have also been highlighted.
Covid impact on selected sectors of indian stock market sanika yadavSanika Yadav
This is a study report on the Impact of COVID-19 on selected sectors of the Indian Stock Markets.
The market reflects sentiments of the investors and this time it seems to project a V-shaped recovery indicating the return of normalcy.
But the real question lies in whether it matches the ground reality?
Survival of the fittest -
COVID-19 has compelled businesses to restrategize and revamp their business models to stay relevant. It has lead to many market disruptors resulting in new entrants reaching successes while the traditional businesses struggling to operate.
This report discusses some key impacts on sectors like Pharma, IT and Automobile.
Strategic Analysis of the Indian Pharmaceutical Contract Manufacturing Market...Aiswariya Chidambaram
The Indian Pharmaceutical CMO market has been analyzed and assessed with respect to APIs and finished dose formulations (solids, liquids and injectables). Strategic recommendations for the success of market participants have been provided.
This ppt gives an overview of the Indian Pharmaceutical sector. We have concentrated on 5 aspects of the sector and analysed it. The covered heads are history, business model, Marketing, Competitor analysis, Financials and Trends.
Brief Report on the Indian Pharmaceutical Industry - 2011david_singer
The document summarizes the pharmaceutical industry in India. It provides an overview of the industry, noting that it is highly fragmented with over 20,000 registered units and is a $4.5 billion industry growing annually by 8-9%. It also profiles some of the largest pharmaceutical companies in India, including Ranbaxy, Dr. Reddy's Laboratories, and Cipla, and discusses their operations, market shares, and R&D investments. The industry is a major exporter of generic drugs and has a competitive advantage due to its skilled workforce and cost-effective production capabilities.
China organosilicon industry market demand prospects and investment strategy ...Qianzhan Intelligence
The document provides an overview and analysis of the organosilicon industry in China. It discusses the industry's development trends, market demand prospects, and investment strategies from 2013 to 2017. It analyzes factors such as the industry's structure, key players, market segments, supply and demand dynamics, import/export activities, competitive landscape, and development prospects. The report is intended to help organosilicon manufacturers, R&D institutions, marketing companies, and investors better understand the industry and identify opportunities.
China organosilicon industry market demand prospects and investment strategy ...Qianzhan Intelligence
The document is a report on the organosilicon industry market in China from 2011-2017. It provides an overview of the industry, including definitions and product categories. It also analyzes factors like the industrial chain, development trends, economic indexes, supply and demand balance, import/export market, market environment, and domestic and global competition in the industry. The report aims to help organosilicon companies, R&D institutions, marketing firms, and investors understand the latest industry developments and find opportunities in the growing market.
Stent design aspects and coronary artery disease were discussed. Coronary artery disease is a leading cause of death worldwide. Historical developments in treatments including balloon angioplasty, bare metal stents, and drug-eluting stents were covered. Mechanisms of in-stent restenosis and approaches to prevent it such as mechanical techniques, drug coatings, and biodegradable stents were described. Clinical measures for evaluating restenosis outcomes were defined.
Computer Hub in Ambala ! Batra Computer Centrejatin batra
Batra Computer Centre is An ISO certified 9001:2008 training Centre in Ambala.
We Provide Best Computer Training in Ambala. BATRA COMPUTER CENTRE provides best training in C, C++, S.E.O, Web Designing, Web Development and So many other courses are available.
Nic 2013 registry - Coronary Data Presentation - Dr. Praveen Chandrasaketsinghi
The document summarizes coronary and non-coronary intervention data from 2013 in India. Key findings include: coronary interventions increased to over 216,000, with drug-eluting stents comprising 78% of stents used. Primary PCI for acute MIs rose to over 24,000 cases. Non-coronary interventions included over 5,000 peripheral, 13,000 valve, and 7,700 structural heart procedures. The data highlights growth in interventional cardiology in India but notes the need for a national prospective registry to improve data collection.
This document summarizes postmarketing studies comparing the Russian-made Calypso drug-eluting stent to analogous foreign stents. It describes two ongoing comparative registry studies - E-Calypso and Patriot - that are evaluating the safety and efficacy of the Calypso stent versus competitors like the Resolute Integrity and Xience Prime stents. The document outlines the study designs, endpoints, inclusion/exclusion criteria and administrative details of the comparative studies which are taking place in Russia through 2016. It also provides technical specifications and performance data indicating the Calypso stent is competitive with leading foreign stents while offering significant cost savings.
The Future of Market Access – The Patient PicturePM Society
The document discusses challenges and potential solutions around patient access to new medical treatments. It notes that patients want different things from treatment, including choice, involvement in decisions, convenience and durable remissions. However, there are barriers like a lack of real-world data to inform approvals and pricing, and current policies do not always provide appropriate access. The speaker argues that a new, integrated model is needed that considers the patient perspective across the entire process from research to policy. Silos between different parts of the system should be broken down and value should be assessed more broadly than just clinical trials.
Market access the challenges for medical devices Amy Morgan
With increased incidences of reimbursement rejections by payers and a growing usage of pricing and reimbursement tools market access is becoming increasingly restricted…
MT5007: The coronary stent revolution (A group project for the Management of ...Stefan
This project tracks the development of coronary artery disease interventions, ranging from early method of cardiac bypass to balloon angioplasty to the development of biomedical stents. Analyses of the competitive climate in the biomedical stents industry is discussed. New market and technology strategies are proposed for a regional MNC to leverage domestic industry infrastructure within emerging economies accompanied by a projected 30% growth in CAD due to increased consumption trends and lifestyle factors, e.g. smoking.
This document summarizes coronary stents, including their purpose, types, history, procedure for placement, and future advancements. Stents are small mesh devices that are placed in arteries to keep them open and improve blood flow after balloon angioplasty. There are bare metal stents and drug-eluting stents, which combat re-narrowing after placement. The first coronary stent was placed in 1986, and drug-eluting stents were introduced in 2001 to further reduce re-narrowing. Placement involves threading a catheter through an artery to the blockage and expanding a balloon and stent to open the artery. Future advancements include bioresorbable polymers that dissolve after artery healing is complete.
The document discusses one-stage and two-stage implant placement procedures. In a two-stage procedure, implants are placed and submerged under soft tissue and allowed to heal for 2-6 months before being exposed in a second surgery. In a one-stage procedure, the implant or abutment emerges through soft tissue at initial placement. The document outlines the steps for implant site preparation, placement, flap closure, post-operative care, and second-stage exposure surgery in a two-stage approach.
This document discusses different designs of coronary stents. It begins by providing background on the development of coronary stents and their approval for use. It then describes some of the earliest stent designs, including the Gianturco-Roubin coil stent and the Palmaz-Schatz slotted tube stent. The document goes on to discuss various aspects of stent design that can impact performance, such as the geometric configuration, materials used, coatings, and drug-eluting capabilities. Key design considerations like strut thickness, number of struts, and mechanical properties are also reviewed.
A stent is a small, expandable tube. During a procedure called angioplasty, the stent is inserted into a coronary artery and expanded using a small balloon. A stent is used to open a narrowed or clotted artery.
The growth of healthcare sector in India will be a major boost for the device market. Rising incidence of lifestyle diseases due to changing lifestyles of Indian population and lack of physical exercise will be another feather in the hat. Other factors that will contribute to its glory are favorable demographics, increasing government focus on the sector, rapid spread of the health awareness and India emerging as the medical tourism hub of the world.
Contact us:
Niir Project Consultancy Services
106-E, Kamla Nagar, Near Spark Mall,
New Delhi-110007, India.
Email: npcs.ei@gmail.com , info@entrepreneurindia.co
Tel: +91-11-23843955, 23845654, 23845886, 8800733955
Mobile: +91-9811043595
Fax: +91-11-23841561
Website :
http://www.niir.org
http://www.entrepreneurindia.co
Tags
Disposable Glove Making Machine, Disposable medical syringe & needle production plant, Disposable Plastic Gloves, Disposable Plastic Syringe: Manufacturing Business Idea, Disposable Plastic Syringes Manufacturing Plant, Disposable Surgical Gowns Products, disposable surgical wear manufacturing, Disposable syringe - Small Industry, Disposable syringe making machine, Disposable syringe manufacturing plant, Disposable syringe manufacturing process, Disposable Syringe Plant, Glove manufacturing process,Healthcare Disposable Surgical Instruments, Hospital Surgical Items List, How to Manufacture Flexible PVC Blood Bags, How to manufacture Medical and Surgical Disposable products, How to manufacture Medical Disposable products, How to manufacture Surgical Disposable products, How to Start a Medical and Surgical Disposable Production Business, How to Start Medical and Surgical Disposable production Industry in India, Injection needle manufacturing process,List of disposable items used in hospitals, Manufacturing medical plastic like catheters and syringes, Materials for medical device packaging, Medical and Surgical Disposable products manufacturing Industry in India, Medical Based Small Scale Industries, Medical Blood Bag Production, Medical device manufacturing industry, Medical device manufacturing process, Medical Device Packaging, Medical Device Packaging Industry: Healthcare Packaging, Medical Devices and Surgical Disposables in India, Medical Disposable Blood Bag, Medical Disposable Products, Medical Disposable Products for hospital and surgical use, Medical disposables list, Medical disposables manufacturing in India, Medical Disposables and Surgical Disposables, Medical Glove Plant, Medical Products, Hospital Products, Surgical Products manufacturing, Medical Products: Surgical Blades, Urine Bags, Catheters, Most Profitable Surgical Disposable products manufacturing Business Ideas, New small scale ideas in Surgical Disposable products manufacturing industry, Process technology books, Project for startups, Specialty Surgical Gloves, Starting a Medical products manufacturing Business
The document provides an overview of the medical devices market in India. Some key points:
- The Indian medical devices market was valued at Rs. 77,539 crore (US$ 11 billion) in 2020 and is expected to grow at a CAGR of 35.4% to reach Rs. 352,450 crore (US$ 50 billion) by 2025.
- India has an import dependency of 75-80% for medical devices, with exports valued at Rs. 14,802 crore (US$ 2.1 billion) in 2019 projected to increase at a CAGR of 29.7% to Rs. 70,490 crore (US$ 10 billion) by 2025.
India Cardiovascular Market Analysis Sample ReportInsights10
The India cardiovascular market is projected to grow from $1.00 Bn in 2022 to $1.79 Bn in 2030 with a CAGR of 7.52% for the year 2022-2030. Increased incidence of cardiovascular diseases and improvements in diagnosis and treatment options in India are the major drivers for the growth of the market. To get a detailed report, contact us at - info@insights10.com
The market for CVDs in India is growing rapidly because of the complex lifestyle changes associated with urbanization and the epidemiologic and nutritional transitions that accompany economic development.
The cardiovascular diseases includes disorders of heart & blood vessels especially and includes the life-threatening conditions such as coronary heart disease, hypertension and hyperlipidaemia. Cardiovascular diseases results in conditions such as myocardial infraction i.e. heart attacks and strokes. The age-standardized prevalence of CVD in India per 100,000 people was around XX during the year 2019-2028.
It is noted that the prevalence of heart diseases and stroke in India has increased by XX% from 1990 to 2019. This shows the rising burden of the diseases on India. During the year 2016-19, CVD alone contributed to XX% of the total deaths in India among which, heart disease caused XX% whereas stroke contributed XX% of total deaths. The most prevalent conditions in India include ischemic heart disease, hypertensive heart disease, and cerebrovascular disease. One in 4 deaths in India are now because of CVDs with ischemic heart disease and stroke responsible for >80% of this burden.
The Indian government spends just 1.2 % of the GDP on the health sector, which is among the lowest in the world. The market drivers for cardiovascular diseases are large population, growing economic prosperity, and the disease burden. The leading medical devices company spends approximately XX% in R&D as percentage ratio to sales. The growth of the cardiovascular devices market is primarily attributed to the increasing acquisitions and collaboration activities and increasing rate of obesity. On the other hand, growth opportunities in the developing nations and declining prices of coronary stents are likely to have a positive impact on the growth of the Asia Pacific cardiovascular devices market in the coming years. The technological advancements are leading to increasing adoption of the pacemakers, and one of the recent advancements include the development of a leadless pacemaker that is one-tenth the size of the predecessor devices by Medtronic.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us at info@insights10.com
India Ophthalmology Therapeutics Market Report 2022 to 2030Insights10
Indian Ophthalmology Therapeutics Market size stood at around USD XX billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of around XX% during the forecast period (2019-2028).
The document summarizes the Indian medical device market. It finds that the market was worth $5.1 billion in 2012 and is expected to reach $9.2 billion by 2016, growing at a 15.8% CAGR. Currently, 72% of medical devices sold in India are imported, with imports favored due to taxation policies. The market is dominated by multinational companies in high-tech segments, while domestic players cater to lower-tech areas. The top opportunities are in medical and diagnostic equipment, expected to reach $6 billion and grow over 17% by 2017. Key drivers of growth are increasing incomes, insurance coverage, and government support of healthcare. Barriers include low penetration, over-reliance on
The document is the annual report of the Government of India's Ministry of Chemicals & Fertilizers Department of Pharmaceuticals for the year 2020-21. It provides an overview of the pharmaceutical and medical devices industry in India. Some key points:
- India is the 3rd largest pharmaceutical producer by volume globally and supplies affordable generic drugs worldwide. It also accounts for 60% of global vaccine production.
- The medical devices industry in India has potential to reach $50 billion by 2025, currently ranking among the top 20 global markets.
- Exports and imports of pharmaceuticals and medical devices in 2019-20 are provided, with exports of medical devices growing and reducing the trade deficit.
Indian nutraceuticals market forecast to 2017IBNARESEARCH
This document provides a 120-page report on the Indian nutraceuticals market forecast from 2017. It finds that India's growing affluent middle class is increasingly health conscious and aware of nutraceuticals and dietary supplements. The report segments the market into functional foods, functional beverages, and dietary supplements and provides historical data and forecasts for each segment from 2007-2017. It also analyzes import/export trends, pricing, distribution channels, key players and marketing in the industry. The report aims to help readers understand growth opportunities and challenges in the rapidly expanding Indian nutraceuticals sector.
The Indian medical devices market is growing rapidly due to increasing demand, policy support from the government, and opportunities in exports. The market is expected to increase from $10.36 billion in FY20 to $50 billion by 2025 growing at a CAGR of 37%. Government initiatives such as allowing 100% FDI, production linked incentive schemes, and plans to establish new medical device parks are boosting investment and manufacturing in the industry. Rising healthcare infrastructure in India and amendments to medical device regulations are also driving the growth of the medical devices market.
Medical Nonwoven Disposables Market Analysis, Size, Share, Growth To 2020 by...Grand View Research
Rapidly growing geriatric population base is another high impact rendering driver for the medical nonwoven disposables market as aging is considered as one of the greatest risk factor for the development of incontinence
For More Information Visit - http://www.grandviewresearch.com/industry-analysis/medical-nonwoven-disposables-market
2012 Global and China cardiac stent industry depth research reportReportsnReports
This 234-page report provides an in-depth analysis of the global and Chinese cardiac stent industry from 2009-2013. It covers topics such as market size, production capacity, market share, pricing, costs, and competitive landscape of the top 16 global and 6 Chinese companies. It also analyzes industry trends, opportunities, challenges, and provides strategic recommendations. The report aims to support customers in competitive analysis, development planning, and investment decision making within the cardiac stent industry.
India Cardiovascular Devices Market Size, Share, Trend, Analysis and Forecast...TechSci Research
The document provides an overview and scope of a report on the India cardiovascular devices market from FY2017 to FY2027. It includes segmentation of the market by type, application, end user, region, and competitive analysis. Sample data on market size, growth rates, and shares are also presented. The market is expected to grow due to increasing cases of cardiovascular diseases in India driven by risk factors like rising geriatric population, lifestyle diseases, and diabetes.
India Vacuum Blood Collection Tube Market, Growth Rate, Covid 19 Impact, Economic Impact, Size, Share, Trend, Drivers, Competitive Landscape, Opportunity, Limitations, Technological Landscape, Regulatory Framework, PESTEL Analysis, PORTER’s Analysis and Demand Forecast upto 2027
The vacuum blood collection tube market reached USD 71.09 million in 2019 and is likely to reach USD 160.87 million by the end of 2027 by registering a 10.82 % CAGR across India. It is attributed to the propelling incidence of infectious diseases, which is anticipated to boost the market. Contagious diseases have made the most significant contribution to any cause to hospital admissions. In recent years, emerging and re-emerging infectious diseases in developed countries, including India, are presenting a public health danger.
For More Details, Click Here: https://www.entrepreneurindia.co/book-detail/1266/india+vacuum+blood+collection+tube+market
Contact us
Niir Project Consultancy Services
An ISO 9001:2015 Company
106-E, Kamla Nagar, Opp. Mall ST,
New Delhi-110007, India.
Email: npcs.ei@gmail.com , info@entrepreneurindia.co
Tel: +91-11-23843955, 23845654, 23845886
Mobile: +91-9097075054, 8800733955
Website: www.entrepreneurindia.co , www.niir.org
The document provides an overview of the pharmaceutical industry in India. Some key points:
- The Indian pharmaceutical industry is expected to grow at a CAGR of 12.89% until 2020 to reach $55 billion in size.
- India accounts for 20% of global exports in generics drugs and exports were $16.8 billion in 2016-17, expected to reach $20 billion by 2020.
- The generics market in India stands at $26.1 billion in 2016 and has strong growth potential.
- Major segments of the pharmaceutical industry in India include active pharmaceutical ingredients, formulations, biosimilars, and contract research and manufacturing.
India Physiotherapy Market Report 2022 to 2030Insights10
India's physiotherapy market size was valued at $0.96 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 8.85% from 2022 to 2030 and will reach $1.9 Bn in 2030. This market is expected to grow due to an increase in the number of people suffering from chronic conditions including diabetes and obesity as well as an aging population. The market is segmented by Product Type, Application Type, and End User. The key players are BTL Industries. Performance Health, ITO Co., Ltd., Enraf-Nonius B.V., and others.
India IVD (Instruments & Reagents) Market, Share, Registration, Regulations &...iGATE RESEARCH
iGATE Research has released a research report on “India IVD (Instruments & Reagents) Market, Share, Registration, Regulations & Classification of IVD and Key Players Analysis - Forecast to 2025”
Click here to view the complete report: http://igateresearch.com/FullReportDetail.php?p=154
Contact US
iGATE Research PVT LTD
Ravi Sinha
Sales Manager
Marketing and Sales Divison
Email: ravi.sinha@igateresearch.com
Contact: +91-858-684-0791, +91-821-092-7469 (INDIA)
Web: www.igateresearch.com
India Urology Devices Market [2029]: Navigating Opportunities and ChallengesKumar Satyam
According to the TechSci Research report titled “India Urology Devices Market Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2019-2029,” the India Urology Devices Market is poised for significant growth. The market, valued at USD 1.10 billion in 2023, is projected to grow at a compound annual growth rate (CAGR) of 5.10% through 2029. This growth is driven by various factors, including collaborations and partnerships among leading companies, the rising prevalence of chronic diseases, and the increasing demand for advanced urology devices. This comprehensive report will delve into the market dynamics, recent trends, drivers, competitive landscape, and benefits of the research report, providing a detailed analysis of the India Urology Devices Market.
Collaborations and Partnerships
Collaborations and partnerships among leading companies are crucial in driving the growth of the India Urology Devices Market. These strategic alliances enable companies to merge their expertise, strengthen their market positions, and offer innovative solutions. By combining resources, companies can enhance their research and development capabilities, expand their product portfolios, and improve their distribution networks.
Rising Prevalence of Chronic Diseases
The increasing prevalence of chronic diseases is a significant driver for the demand for urology devices. Chronic conditions such as diabetes, hypertension, and heart disease often lead to urological complications, necessitating the use of advanced urology devices for diagnosis, treatment, and ongoing care. For instance, diabetes is a leading cause of kidney disease, and managing urological complications related to diabetes requires devices like dialysis machines, catheters, and stents.
Government Initiatives and Guidelines
The Indian government has implemented several guidelines and initiatives to address the growing burden of urological diseases. For example, the Urological Society of India's guidelines for benign prostatic hyperplasia/obstruction (BPH/BPO) advocate the use of surgical treatments, including advanced laser devices. These guidelines are expected to propel the adoption of urology devices during the forecast period.
Medical Electronics Market Size, Share & Forecast | TechSci ResearchTechSci Research
According to www.techsciresearch.com latest report- Global Medical Electronics Market By Product Type (Therapeutic and Diagnostics), By End-user (Hospital, Ambulatory Surgical Center, Clinic & Others), By Region (North America, Europe, Asia-Pacific & Others), Competition, Forecast & Opportunities, 2024.
Report URL- https://www.techsciresearch.com/report/medical-electronics-market/3896.html
According to Pharmaion report “India Hospital Market Report”, hospital market in India is projected to reach US$ 189 billion by 2020. Growing incidences of non-communicable diseases, increasing demand for high quality healthcare, booming medical tourism and rising number of foreign investments towards establishing new hospitals is driving the country’s hospital market.
The healthcare sector in India is poised for strong growth over the coming years. Key points:
- The Indian healthcare market is expected to reach US$ 372 billion by 2022, growing at a CAGR of over 16%. Rising incomes, greater health awareness, and lifestyle diseases are driving demand.
- Infrastructure is also expanding rapidly with the number of doctors increasing to over 841,000 in 2017 and medical colleges reaching 476 in 2018.
- The government has also introduced favorable policies like tax benefits and increased funding to encourage private sector growth and increase healthcare access across the country through programs like Ayushman Bharat.
- Emerging trends include a shift to non-communicable diseases
Similar to Indian coronary stent market forecast to 2019 (20)
Indian led lighting market forecast to 2019IBNARESEARCH
This document provides an overview and market forecast of the Indian LED lighting market from 2014-2019. It covers topics such as the policy and regulatory environment, manufacturing and production in India, imports and exports, pricing trends, consumer behavior, the current market size and segmentation, and forecasts for future growth. The market is growing rapidly due to government support and promotion of LED lighting to improve energy efficiency. Street lights and downlights currently have the largest volume shares but the market for retrofit lamps and luminaires is growing faster. The document provides numerous tables and figures analyzing trends in each market segment.
Indian chocolate market forecast to 2019IBNARESEARCH
This document provides a summary of a 130-page market research report on the Indian chocolate market forecast to 2019. The report is divided into 10 chapters covering topics like regulations, production, imports/exports, consumers, pricing, and the current market size. It also includes tables of import/export data by category and country from 2009-2014. The goal of the report is to help manufacturers, importers and exporters better understand opportunities and growth in the Indian chocolate industry.
Indian biscuits market forecast to 2019IBNARESEARCH
This document provides a summary of the "Indian Biscuits Market Forecast to 2019" market research report published by IBNA Research. The 130-page report analyzes the Indian biscuits market, including historical data from 2009-2014 and forecasts to 2019. It covers market size, growth, segmentation, import/export trends, major players, regulations, pricing and more. The report categorizes the market into 6 biscuit segments and provides detailed analysis of trends in each segment.
Indian kid's wear market forecast to 2018IBNARESEARCH
This document provides a market forecast for the Indian kids' wear market from 2014 to 2018. It includes 10 chapters that cover topics such as the demographic and economic landscape of India, regulations and policies, retail categories and formats, consumer trends, market size and share for boys' and girls' kids' wear, and profiles of major Indian and foreign apparel companies. The market for kids' wear is projected to grow steadily over the forecast period, driven by India's young population and rising incomes. Key segments like boys' tops and girls' dresses are expected to see particularly strong growth.
Indian men's wear market forecast to 2018IBNARESEARCH
This document provides an overview and market analysis of the Indian men's wear market from 2009-2018. It discusses the market size, segmentation, share and growth over time. It also analyzes the key demographic trends in India, retail policies and regulations, taxation, consumer spending patterns, major players and retail formats in the industry. The document is divided into 10 chapters covering topics such as population trends, policy environment, taxation, retail real estate, consumer behavior and market forecasts. It provides detailed analysis through text and over 50 tables of data on the Indian men's wear sector.
Indian women's wear market forecast to 2018IBNARESEARCH
This document provides an overview and forecast of the women's wear market in India from 2014 to 2018. It discusses the demographic and economic landscape in India and outlines the key growth regions. The report also examines the retail policy environment, including foreign investment rules and regulations. It analyzes the women's wear market size, share, growth and provides a forecast from 2014-2018. The report includes profiles of major Indian and foreign apparel retailers and brands. Key factors influencing the industry such as distribution channels, marketing and online sales are also covered.
Indian wine market forecast to 2018.docx copyIBNARESEARCH
This document provides a summary of the "Indian Wine Market Forecast to 2018" research report published by the Indian Business News Agency. The 280-page report contains 10 chapters that analyze the Indian wine market, including production, regulations, pricing, imports/exports, major companies, and market size forecasts. It aims to help wine manufacturers and exporters better understand opportunities in the growing Indian market. The report provides extensive statistics, analysis, and insights into the various aspects of the Indian wine industry.
Indian footwear retail market forecast to 2017IBNARESEARCH
This document provides a summary and table of contents for the report "Indian Footwear Retail Market Forecast to 2017". The 194-page report contains detailed statistics and analysis of the Indian footwear retail market segmented into men's, women's, and kid's footwear. It provides past and present market size and growth data from 2007-2012 for each segment, and forecasts the market outlook from 2013-2017. The report also analyzes consumer behavior, market share by major players, distribution networks, and other aspects of the Indian footwear retail industry.
Indian food retail market forecast to 2017IBNARESEARCH
This document is a 185-page report published in September 2012 by Indian Business News Agency that analyzes and forecasts the Indian food retail market until 2017. It segments the market into categories like fruits/vegetables, dairy, meat, etc. and provides statistics on production, retail space, rental rates, and market size/growth for each segment. The report also examines factors influencing consumers and provides profiles of major food retail companies in India. Foreign investment policies are discussed as well as the impacts of allowing foreign retailers to enter the Indian market in 2012.
Indian Olive Oil Market Forecast to 2017IBNARESEARCH
This document provides a summary and table of contents for the market research report "Indian Olive Oil Market Forecast to 2017" published by IBNA Research in August 2012. The 160-page report contains 11 chapters analyzing the past, present, and future outlook of the Indian olive oil market through 2027. It provides statistics on olive oil production, consumption, imports, pricing, distribution, and consumer trends in India. The report aims to help olive oil manufacturers and exporters better understand opportunities in the growing Indian market.
This document provides a 155-page report on the forecast of the Indian apparel retail market from 2012 to 2017. It finds that the market has grown rapidly over the past five years and is expected to continue growing at a 12.5% compound annual growth rate through 2017. The report segments the market into men's wear, women's wear, kids' wear for boys and girls, and unisex apparel. It provides historical data, market share and forecasts for each segment. Key factors influencing growth are increasing population, urbanization, incomes and consumer spending. The report also examines industry regulations, major players and distribution channels.
1. PUBLISHED ON NOVEMBER 1
17, 2014
IBNARESEARCH
CORONARY STENT
INDIAN BUSINESS NEWS AGENCY (IBNA)
730 SARVAHIT APARTMENTS
SECTOR 17 A, DWARKA
NEW DELHI 110078
INDIA
IBNA
A DIVISION OF INDIAN BUSINESS NEWS AGENCY
INDIAN
MARKET
FORECAST TO 2019
2. INDIAN CORONARY STENT MARKET FORECAST TO 2019 2
INDIAN CORONARY STENT MARKET FORECAST TO 2019
Pages: 120
Publication Date: November 17, 2014
Single User Licence Price: US$ 1,200
Corporate User Licence Price: US$ 2,000
Heart diseases are on the rise in India. It is estimated that 10 percent of urban adult
population and 5 percent of rural adult population suffer from some form of heart
diseases and 20-30 percent of them require specialized investigation and treatment to
prevent deaths due to heart ailments and coronary vascular diseases (CVD).
In view of the above fact IBNA Research, a division of Indian Business News Agency
(IBNA) has launched a new market research report titled “Indian Coronary Stent
Market Forecast to 2019”. The new research report revealed vivid and elaborate
market information. For the decision makers of the coronary stents manufacturing
companies this report, no doubt, will be a helpful tool to get the clear picture of the
Indian market.
The report starts with an introduction of India's demographic and macroeconomic
indicators, including focus on Indian healthcare sector.
Chapter Two of the report discusses the government regulations, policy and different
kinds of licences and registrations for medical devices industry. The chapter brings
the rules and regulations of imported medical devices like coronary stents in India. It
also provides market entry strategy, explains entrance routes and analyses the most
relevant options for the foreign medical devices companies to enter in the market.
Chapter Three covers the duties and taxes on medical devices, especially coronary
stents, including detail discussion on tax rates imposed by the central government as
well as the state governments.
Chapter Four explains the overall medical devices industry and the production of
coronary stents in India. The chapter provides the information needed to understand
the dynamics of the medical devices industry in the country.
Chapter Five discusses the import and exports of medical devices, especially the
coronary stents. The chapter provides contact information of major importers and
exporters of coronary stents India.
Chapter Six highlights the Indian consumer income grouping, consumer classes, their
characteristics, behavior and preferences. The chapter will help the foreign medical
devices companies to understand the mental makeup of the Indian consumers.
Chapter Seven provides prices of different categories of coronary stents in the Indian
market. The chapter discusses the mechanism of formation of price of coronary
stents in the country. Also, the chapter discusses the mal practices in the stent prices
in India.
Chapter Eight provides elaborate coverage of Indian coronary stent market. Providing
detail statistics, the chapter analyses the market size, market growth and market
share. The chapter categorizes Indian coronary stent market into three product
categories – Drug Eluting Stent, Bare Metal Stent and Absorbable Stent – to provide a
detailed overview of past and present performance, both in value and volume terms,
www.ibnaresearch.in
3. INDIAN CORONARY STENT MARKET FORECAST TO 2019 3
of each segment. The segment-wise future outlook has been given in the report which
will help readers to identify the future growth spots and the market target. The chapter
also provides profiles of the 20 foreign and indigenous coronary stent manufacturing
companies and their Indian distributors, to help clients understand the market, its
structure and progress in the coming years.
Chapter Nine highlights various distribution networks existing in the Indian market
and the market trends, potential future growth areas, and challenges for the sector.
If you are in the Coronary Stent industry take a look on the Table of Content and the
Figures and Tables that are provided with this description and we are sure that you
will benefit greatly from the information compiled in "Indian Coronary Stent Market
Forecast to 2019".
www.ibnaresearch.in
4. INDIAN CORONARY STENT MARKET FORECAST TO 2019 4
TABLE OF CONTENT
www.ibnaresearch.in
CHAPTER ONE: INTRODUCTION
1. Introduction
1.1.1 Demographic Distribution of Population
1.1.2 Demographic Distribution of Population on the basis of Age
1.1.3 Population in the Major Cities
1.1.4 Projected of Population 2015-2026
1.2 Annual GDP growth
1.2.1 India’s Real GDP Growth
1.3 Healthcare in India
1.3.1 Cardio Vascular Diseases in India
1.3.2 Healthcare Infrastructure in India
1.3.3 List of Hospitals in India
CHAPTER TWO: POLICY & REGULATIONS
2. An Overview of Regulatory Policies for Indian Medical Devices Industry
2.1 Organizational Structure of Regulatory Bodies
2.2 Licences Required for Import, Sale, Manufacture and Loan of Medical Devices in India
2.3 Licences Required for Manufacturing a Notified Medical Device in India
2.4 Procedure for Importing a Notified Medical Device into India
2.5 Procedure for Manufacture or Import of New Notified Medical Devices
2.6 Procedure for Clinical Trials
2.7 Compliance for Product Standards
2.8 Labeling Requirements
2.9 Requirement of Good Manufacturing Practices (GMP)
2.10 Provision of Penalties
2.11 Regulations for Advertising and Sales Promotion of Medical Devices
2.11.1 Drugs and Magic Remedies (Objectionable Advertisement) Act, 1954
2.12 Provisions for Patent Protection
2.12.1 Provision for Patentability of Medical Devices
2.12.2 Provision for Convention Application for Patent in India
2.12.3 Provision of Infringement
2.12.4 Provision of Parallel Imports
2.12.5 Provision of Enforcement
2.12.6 Rights Prior to the Grant Provision
2.12.7 Provision for Secrecy
2.13 Data Exclusivity Law
2.14 Trademarks Law
2.15 Proposed New Legislations for Medical Devices Industry
2.16 Cardiological Society of India (CSI) & National Intervention Council (NIC)
2.18 Labour Laws
2.19 Indian System of Counting Money
CHAPTER THREE: DUTIES & TAXES
3. An Overview of Tax Regime in India
3.1 Direct Taxes
3.2 Indirect Taxes
3.2.1 Service Tax
3.2.2 Value Added Tax (VAT)
3.2.3 Customs duties
3.2.4 Central Excise Duties
3.2.5 Central Sales Tax (CST)
3.3 Tax Reforms
5. INDIAN CORONARY STENT MARKET FORECAST TO 2019 5
CHAPTER FOUR: INDUSTRY & PRODUCTION
4. An Overview of Indian Medical Devices Manufacturing Industry
4.1 Production of Medical Devices in India
4.1.1 Production of Coronary Stents in India
4.2. Technology Used by the Medical Devices Industry in India
4.3 Government’s Support
4.4 Industry Associations
CHAPTER FIVE: IMPORT & EXPORT
5. An Overview of Imports & Exports of Medical Devices Especially Coronary Stents
5.1 Imports of Coronary Stents in India
5.1.1 Name & Contact Addresses of Major Indian Importers of Coronary Stents
5.2 Exports of Coronary Stents from India
5.2.1 Name & Contact Addresses of Major Indian Exporters of Coronary Stents
CHAPTER SIX: CONSUMERS
6. Overview
6.1 Income Grouping & Consumer Classes
6.3. Consumer Spending on Healthcare
6.4. Indian Consumer’s Perception about Foreign Products
6.5. Factors that Influence the Consumers
CHAPTER SEVEN: PRICE
7. Current trends of Coronary Stents Prices in India
7.1 Prices of Coronary Stents in India under Central Government Health Scheme (CGHS) &
Private Hospitals
7.2 Formation of Retail Prices of Coronary Stents in India
7.3 Disparity in Coronary Stent Prices in India
7.4 Malpractice in Coronary Stents Prices in India
CHAPTER EIGHT: MARKET
8. Current Trends in Indian Coronary Stent Market
8.1 Coronary Stent Market Segmentation by Product
8.1.1 Market Structure of Coronary Stent
8.2 Market Size of Coronary Stents 2009-10 to 2013-14
8.3 Market Growth of Coronary Stent 2008-09>2009-10 to 2012-13>2013-14
8.4 Market Share of Coronary Stent 2009-10 to 2013-14
8.5 Market Forecast of Coronary Stent 2014-15 to 2018-19
8.6 Coronary Stents Manufacturing Companies (Both Indigenous & Foreign) doing Business in
Indian Market
8.7 Profiles of Selected Major Coronary Stent Companies
8.7.1 Abbott Vascular
8.7.2 Arthesys
8.7.3 B. Braun Melsungen AG
8.7.4 Biosensors International Technologies Pte. Limited
8.7.5 Boston Scientific Corporation
8.7.6 Cardionovum GmbH
8.7.7 Eurocor GmbH
8.7.8 Iberhospitex SA
8.7.9 InspireMD Limited
8.7.10 Medtronic Ireland
8.7.11 Meko LasertrahI-Materialbearbeitunge
8.7.12 Meril Life Sciences
www.ibnaresearch.in
6. INDIAN CORONARY STENT MARKET FORECAST TO 2019 6
8.7.13 MicroPort Medical (Shanghai) Co. Limited
8.7.14 Opto Circuits India Limited
8.7.15 OrbusNeich Medical B.V
8.7.16 Rontis AG
8.7.17 Sahajanand Medical Technologies Private Limited
8.7.18 Terumo Corporation
8.7.19 Vascular Concepts Limited
8.7.20 Vasmed Technologies Limited
CHAPTER NINE: DISTRIBUTION
9. Overview
9.1 Physician Owned Distributorships
9.2 Distribution Structure
9.3 The Major Buyers of Stents in India
9.4 Distribution Channel through the Private Hospitals
9.5. Trade Margins
9.6 Terms of Credit
CHAPTER TEN: MARKETING
10. Introduction
10.1. Exhibitions & Trade Shows
10.2. Medical Conferences & Sponsorship
10.3 Liaison with Doctors and Hospitals
10.4 Media & Public Relation
10.5 Other Forms of Marketing and Communications
Tables:
Table 1: Cities of 1 Million and Above Inhabitants
Table 2: Projected Total Population by Sex 2015-2026
Table 3: GDP Growth in India 2009-2013
Table 4: Real GDP Growth in India 2009-2013
Table 5: Top Ten Causes of Death in India (Age 25 to 69 as Percentage)
Table 6: Top Ten Causes of Death in India (All Ages as Percentage)
Table 7: State & Union Territory Wise Number of Government Hospitals, Beds, Allopathic Doctors and
Dental Surgeons
Table 8: List of Notified Medical Devices in India
Table 9: Information on Licences, Registration Certificates & Permissions from Govt. of India &
State Health Authority
Table 10: General Information – Medical Devices Regulation Bill, 2006 & Drugs and Cosmetics
(Amendment) Bill, 2013
Table 11: State wise Value Added Tax (VAT) Rates on Medical Devices
Table 12: Computation of Customs Duties on Coronary Stents
Table 13: Category wise List of Major Medical Devices Products Manufacture in India
Table 14: Name & Contact Address of Indian Importers of Coronary Stents
Table 15: Name & Contact Address of Indian Exporters of Coronary Stents
Table 16: Indian Consumers – Income Groups
Table 17: Indian Consumer Classes
Table 18: Prices of Coronary Stents under Central Government Health Scheme (CGHS) in 2007-8
Table 19: Prices of Coronary Stents under Central Government Health Scheme (CGHS) in 2011-12
Table 20: Prices of Coronary Stents under Central Government Health Scheme (CGHS) in 2013-14
Table 21: Average Prices of Different Product Categories of Coronary Stents under CGHS and
Private Hospitals 2009-10 to 2013-14 (Prices in INR)
Table 22: Volume Percentage of Use of Coronary Stents under Central Government Health Scheme
(CGHS) and Private Hospitals 2009-10 to 2013-14
Table 23: Quantity of Each Product Category of Coronary Stents used under CGHS and Private
Hospitals 2009-10 to 2013-14
www.ibnaresearch.in
7. INDIAN CORONARY STENT MARKET FORECAST TO 2019 7
Table 24: Product Category wise Overall Quantity of Coronary Stents Used under CGHS and Private
Hospitals 2009-10 to 2013-14
Table 25: Coronary Stents Market Size in terms of Volume 2009-10 to 2013-14
Table 26: Product Segment wise Coronary Stents Market Size in terms of Volume 2009-10 to 2013-14
Table 27: Coronary Stents Market Size in terms of Value (INR) 2009-10 to 2013-14
Table 28: Coronary Stents Market Size in terms of Value (US$) 2009-10 to 2013-14
Table 29: Product Category wise Coronary Stents Market Size in terms of Value (INR) under CGHS
and Private Hospitals 2009-10 to 2013-14
Table 30: Product Category wise Coronary Stents Market Size in terms of Value (INR) 2009-10 to
2013-14
Table 31: Product Segment wise Coronary Stents Market Size in terms of Value (US$) 2009-10 to
2013-14
Table 32: Percentage of Volume Growth of Different Product Segments of Coronary Stents Market
2008-09>2009-10 to 2012-13>2013-14
Table 33: Percentage of Value Growth of Different Product Segments of Coronary Stents Market
2008-09>2009-10 to 2012-13>2013-14
Table 34: Percentage of Volume Share of Different Product Segments of Coronary Stents 2009-10 to
2013-14
Table 35: Percentage of Value Share of Different Product Segments of Coronary Stents Market 2009-
10 to 2013-14
Table 36: Percentage Market Share of Coronary Stents Companies 2009-10 & 2013-14
Table 37: Forecast — Market Size of Coronary Stents in terms of Volume 2014-15 to 2018-19
Table 38: Forecast – Percentage of Volume CAGR of Product Segment wise Coronary Stents Market
2014-15 to 2018-19
Table 39: Forecast — Market Size of Different Product Segments of Coronary Stents in terms of
Volume 2014-15 to 2018-19
Table 40: Forecast — Market Size of Coronary Stents in terms of Value (INR) 2014-15 to 2018-19
Table 41: Forecast — Market Size of Coronary Stents in terms of Value (US$) 2014-15 to 2018-19
Table 42: Forecast – Percentage of Value CAGR of Product Segment wise Coronary Stents Market
2014-15 to 2018-19
Table 43: Forecast — Market Size of Different Product Segments of Coronary Stents in terms of
Value (INR) 2014-15 to 2018-19
Table 44: Forecast — Market Size of Different Product Segments of Coronary Stents in terms of
Value (US$) 2014-15 to 2018-19
Table 45: Name & Contact Address of Coronary Stents Manufacturing Companies doing Business in
Indian Market
Table 46: Period of Credit
Table 47: Exhibitions & Trade Shows
Table 48: List & Description of English Daily News Papers & their Circulations
Table 49: List & Description of Hindi Daily News Papers & their Circulations
Table 50: List & Description of English Magazines
Table 51: List & Description of Hindi Magazines
Table 52: List & Description of Business Magazines
Table 53: List & Description of Trade Newspapers & Magazines
Table 54: List & Description of English TV Channels
Table 55: List & Description of Hindi TV Channels
Figures:
Figure 1: Organizational Structure of Regulatory Bodies
Figure 2: Coronary Stent Market Segmentation by Product
Figure 3: Coronary Stents Market Size in terms of Volume 2009-10 to 2013-14
Figure 4: Drug Eluting Stent Market Size in terms of Volume 2009-10 to 2013-14
Figure 5: Bare Metal Stent Market Size in terms of Volume 2009-10 to 2013-14
Figure 6: Absorbable Stent Market Size in terms of Volume 2009-10 to 2013-14
Figure 7: Coronary Stents Market Size in terms of Value (INR & US$) 2009-10 to 2013-14
Figure 8: Market Size of Drug Eluting Stents in terms of Value (INR & US$) 2009-10 to 2013-14
Figure 9: Market Size of Bare Metal Stents in terms of Value (INR & US$) 2009-10 to 2013-14
Figure 10: Market Size of Absorbable Stents in terms of Value (INR & US$) 2009-10 to 2013-14
www.ibnaresearch.in
8. INDIAN CORONARY STENT MARKET FORECAST TO 2019 8
Figure 11: Percentage of Overall Volume Growth of Coronary Stents Market 2008-09>2009-10 to
2012-13>2013-14
Figure 12: Percentage of Volume Growth of Drug Eluting Stents Market 2008-09>2009-10 to 2012-
13>2013-14
Figure 13: Percentage of Volume Growth of Bare Metal Stents Market 2008-09>2009-10 to 2012-
13>2013-14
Figure 14: Percentage of Volume Growth of Absorbable Stents Market 2008-09>2009-10 to 2012-
13>2013-14
Figure 15: Percentage of Overall Value Growth of Coronary Stents Market 2008-09>2009-10 to 2012-
13>2013-14
Figure 16: Percentage of Value Growth of Drug Eluting Stents Market 2008-09>2009-10 to 2012-
13>2013-14
Figure 17: Percentage of Value Growth of Bare Metal Stents Market 2008-09>2009-10 to 2012-
13>2013-14
Figure 18: Percentage of Value Growth of Absorbable Stents Market 2008-09>2009-10 to 2012-
13>2013-14
Figure 19: Percentage of Volume Share of Different Product Segments of Coronary Stents Market
2009-10
Figure 20: Percentage of Volume Share of Different Product Segments of Coronary Stents Market
2010-11
Figure 21: Percentage of Volume Share of Different Product Segments of Coronary Stents Market
2011-12
Figure 22: Percentage of Volume Share of Different Product Segments of Coronary Stents Market
2012-13
Figure 23: Percentage of Volume Share of Different Product Segments of Coronary Stents Market
2013-14
Figure 24: Percentage of Value Share of Different Product Segments of Coronary Stents 2009-10
Figure 25: Percentage of Value Share of Different Product Segments of Coronary Stents 2010-11
Figure 26: Percentage of Value Share of Different Product Segments of Coronary Stents 2011-12
Figure 27: Percentage of Value Share of Different Product Segments of Coronary Stents 2012-13
Figure 28: Percentage of Value Share of Different Product Segments of Coronary Stents 2013-14
Figure 29: Percentage Market Share of Coronary Stents Companies 2009-10
Figure 30: Percentage Market Share of Coronary Stents Companies 2013-14
Figure 31: Forecast — Market Size of Coronary Stents in terms of Volume 2014-15 to 2018-19
Figure 32: Coronary Stents Market Forecast – Product Segment wise Percentage of Volume CAGR
2014-15 to 2018-19
Figure 33: Forecast — Market Size of Drug Eluting Stents in terms of Volume 2014-15 to 2018-19
Figure 34: Forecast — Market Size of Bare Metal Stents in terms of Volume 2014-15 to 2018-19
Figure 35: Forecast — Market Size of Absorbable Stents in terms of Volume 2014-15 to 2018-19
Figure 36: Forecast — Market Size of Coronary Stents in terms of Value (INR & US$) 2014-15 to
2018-19
Figure 37: Coronary Stents Market Forecast – Product Segment wise Percentage of Value CAGR
2014-15 to 2018-19
Figure 38: Forecast — Market Size of Drug Eluting Stents in terms of Value 2014-15 to 2018-19
Figure 39: Forecast — Market Size of Bare Metal Stents in terms of Volume 2014-15 to 2018-19
Figure 40: Forecast — Market Size of Absorbable Stents in terms of Volume 2014-15 to 2018-19
Figure 41: Distribution Structure of Medical Devices in India
www.ibnaresearch.in
9. INDIAN CORONARY STENT MARKET FORECAST TO 2019 9
CONTACT
IBNARESEARCH
A DIVISION OFINDIAN BUSINESS NEWS AGENCY
730 SARVAHIT APARTMENTS • SECTOR 17 A • DWARKA, NEW DELHI 110078 • INDIA
TEL: + 91 11 45094232 • EMAIL: info@ibnaresearch.in • Website: www.ibnaresearch.in
www.ibnaresearch.in